215 related articles for article (PubMed ID: 7790111)
21. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
Nash MA; Lenzi R; Edwards CL; Kavanagh JJ; Kudelka AP; Verschraegen CF; Platsoucas CD; Freedman RS
Clin Exp Immunol; 1998 May; 112(2):172-80. PubMed ID: 9649178
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma.
Sica D; Rayman P; Stanley J; Edinger M; Tubbs RR; Klein E; Bukowski R; Finke JH
Int J Cancer; 1993 Apr; 53(6):941-7. PubMed ID: 8473051
[TBL] [Abstract][Full Text] [Related]
23. Autologous tumor-specific cytotoxicity of tumor-infiltrating lymphocytes derived from human renal cell carcinoma.
Koo AS; Tso CL; Shimabukuro T; Peyret C; deKernion JB; Belldegrun A
J Immunother (1991); 1991 Oct; 10(5):347-54. PubMed ID: 1790142
[TBL] [Abstract][Full Text] [Related]
24. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
25. The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinoma.
Steger GG; Gnant MF; Djavanmard MP; Mader RM; Jakesz R; Pierce W; deKernion JB; Figlin R; Belldegrun A
J Cancer Res Clin Oncol; 1997; 123(6):317-24. PubMed ID: 9222297
[TBL] [Abstract][Full Text] [Related]
26. [Tumor-immune system interaction in renal cell carcinoma and melanomas. Cytokine transcription in tumors at the time of surgical resection].
Zuber M; Filgueira L; Merlo A; Lüscher U; Juretic A; Spagnoli G; Harder F; Heberer M
Schweiz Med Wochenschr; 1994 Jun; 124(22):930-5. PubMed ID: 8029672
[TBL] [Abstract][Full Text] [Related]
27. Altered CD3 chain and cytokine gene expression in tumor infiltrating T lymphocytes during the development of mesothelioma.
Jarnicki AG; Fitzpatrick DR; Robinson BW; Bielefeldt-Ohmann H
Cancer Lett; 1996 May; 103(1):1-9. PubMed ID: 8616801
[TBL] [Abstract][Full Text] [Related]
28. Role of low nuclear grading of renal carcinoma cells in the functional profile of tumor-infiltrating T cells.
Puccetti L; Manetti R; Parronchi P; Piccinni MP; Mavilia C; Carini M; Romagnani S; Maggi E
Int J Cancer; 2002 Apr; 98(5):674-81. PubMed ID: 11920635
[TBL] [Abstract][Full Text] [Related]
29. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
[TBL] [Abstract][Full Text] [Related]
30. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
31. Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2.
Sonouchi K; Hamilton TA; Tannenbaum CS; Tubbs RR; Bukowski R; Finke JH
Am J Pathol; 1994 Apr; 144(4):747-55. PubMed ID: 8160774
[TBL] [Abstract][Full Text] [Related]
32. Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function.
Tartour E; Latour S; Mathiot C; Thiounn N; Mosseri V; Joyeux I; D'Enghien CD; Lee R; Debre B; Fridman WH
Int J Cancer; 1995 Oct; 63(2):205-12. PubMed ID: 7591205
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes.
Maeurer MJ; Walter W; Martin D; Zitvogel L; Elder E; Storkus W; Lotze MT
Scand J Immunol; 1997 Feb; 45(2):182-92. PubMed ID: 9042431
[TBL] [Abstract][Full Text] [Related]
34. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
Ogasawara M; Rosenberg SA
Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
[TBL] [Abstract][Full Text] [Related]
35. Identification of an enriched CD4+ CD8alpha++ CD8beta+ T-cell subset among tumor-infiltrating lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Dal Cin P; Van den Berghe H; Ceuppens JL
Int J Cancer; 1997 Apr; 71(2):178-82. PubMed ID: 9139839
[TBL] [Abstract][Full Text] [Related]
36. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
[TBL] [Abstract][Full Text] [Related]
37. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies.
Pisa P; Halapi E; Pisa EK; Gerdin E; Hising C; Bucht A; Gerdin B; Kiessling R
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7708-12. PubMed ID: 1502188
[TBL] [Abstract][Full Text] [Related]
38. Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma.
Kudoh S; Redovan C; Rayman P; Edinger M; Tubbs RR; Novick A; Finke JH; Bukowski RM
J Immunother; 1997 Nov; 20(6):479-87. PubMed ID: 9409454
[TBL] [Abstract][Full Text] [Related]
39. Differential in situ expansion and gene expression of CD4+ and CD8+ tumor-infiltrating lymphocytes following adoptive immunotherapy in a murine tumor model system.
Evans R; Duffy TM; Kamdar SJ
Eur J Immunol; 1991 Aug; 21(8):1815-9. PubMed ID: 1907916
[TBL] [Abstract][Full Text] [Related]
40. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.
Hathorn RW; Tso CL; Kaboo R; Pang S; Figlin R; Sawyers C; deKernion JB; Belldegrun A
Cancer; 1994 Oct; 74(7):1904-11. PubMed ID: 7521786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
